StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > No additional financing Yet

<< Previous

Bullboard Posts

Next >>

Comment by TrippinAgain01on Nov 15, 2022 9:37am

105 Views

Post# 35099460

RE:RE:RE:No additional financing Yet

Yes Lith, I'm sure the big employers are coming like the phantom large healthcare system of 2019 and other partners like ONCORE lol. I bet there will be big signing very soon. I'm sure they will publish new data and studies to validate Aristotle as well. Then, they will sign the firefighters and be covered by insurance and quickly get on the NASDAQ....

User image